Journal of Aerosol Medicine and Pulmonary Drug Delivery

Mary Ann Liebert, Inc.

Evaluation status available after sign-in

About the journal

Journal of Aerosol Medicine and Pulmonary Drug Delivery is a journal published by Mary Ann Liebert, Inc. in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Mary Ann Liebert, Inc.
ISSN
1941-2711 · 1941-2703
Country
United States
Access
Not open access / not declared

Index listings

  • MEDLINE · 2008-01-01
  • PUBMED · 2014-09-26
Indexing
MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

861

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

73

i10-index

481

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
Portico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
86%
ORCID iDs in current deposits
64%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
J Aerosol Med Pulm Drug Deliv
Source type
journal
NLM unique ID (PubMed)
101475057
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Inhalation and Respiratory Drug Delivery
  • Inhalation and Respiratory Drug Delivery
  • Inhalation and Respiratory Drug Delivery
  • Asthma and respiratory diseases
  • Asthma and respiratory diseases
  • Advanced Drug Delivery Systems
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Pharmaceutical studies and practices
Show all subjects (75)
  • Asthma and respiratory diseases
  • Cystic Fibrosis Research Advances
  • Cystic Fibrosis Research Advances
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Neonatal Respiratory Health Research
  • Neonatal Respiratory Health Research
  • Nanoparticle-Based Drug Delivery
  • Respiratory Support and Mechanisms
  • Respiratory Support and Mechanisms
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • Respiratory Support and Mechanisms
  • Cystic Fibrosis Research Advances
  • Nosocomial Infections in ICU
  • Nosocomial Infections in ICU
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Air Quality and Health Impacts
  • Respiratory and Cough-Related Research
  • Air Quality and Health Impacts
  • Respiratory and Cough-Related Research
  • Antibiotics Pharmacokinetics and Efficacy
  • Particle Dynamics in Fluid Flows
  • Infection Control and Ventilation
  • Infection Control and Ventilation
  • Pharmacy and Medical Practices
  • Neonatal Respiratory Health Research
  • Electrohydrodynamics and Fluid Dynamics
  • Aerosol Filtration and Electrostatic Precipitation
  • Aerosol Filtration and Electrostatic Precipitation
  • Pharmacological Effects and Assays
  • Air Quality Monitoring and Forecasting
  • Pharmacological Effects and Assays
  • Air Quality Monitoring and Forecasting
  • Occupational exposure and asthma
  • Occupational exposure and asthma
  • Granular flow and fluidized beds
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Nasal Surgery and Airway Studies
  • Allergic Rhinitis and Sensitization
  • Allergic Rhinitis and Sensitization
  • Microencapsulation and Drying Processes
  • Infection Control and Ventilation
  • Microencapsulation and Drying Processes
  • Nosocomial Infections in ICU
  • Air Quality and Health Impacts
  • Drug Solubulity and Delivery Systems
  • Advanced Chemical Sensor Technologies
  • Advanced Chemical Sensor Technologies
  • Drug Solubulity and Delivery Systems
  • Medical Imaging Techniques and Applications
  • COVID-19 Clinical Research Studies
  • Atomic and Subatomic Physics Research
  • Particle Dynamics in Fluid Flows
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Atomic and Subatomic Physics Research
  • Drug Solubulity and Delivery Systems
  • Tracheal and airway disorders
  • Particle Dynamics in Fluid Flows
  • Tracheal and airway disorders
  • Radiopharmaceutical Chemistry and Applications
  • RNA Interference and Gene Delivery
  • Smoking Behavior and Cessation

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: